We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

171 hedge funds and large institutions have $503M invested in Filana Therapeutics in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 57 increasing their positions, 52 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 52

1.6% less ownership

Funds ownership: 30.42% → 28.82% (-1.6%)

5% less funds holding

Funds holding: 180 → 171 (-9)

15% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 40

17% less call options, than puts

Call options by funds: $199M | Put options by funds: $240M

34% less capital invested

Capital invested by funds: $757M → $503M (-$254M)

Holders
171
Holders Change
-9
Holders Change %
-5%
% of All Funds
2.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
34
Increased
57
Reduced
52
Closed
40
Calls
$199M
Puts
$240M
Net Calls
-$40.7M
Net Calls Change
-$6.79M

Top Buyers

Rank Fund Capital Flow
1
TI
Think Investments
California
+$10.6M
2
Morgan Stanley
Morgan Stanley
New York
+$10.5M
3
BlackRock
BlackRock
New York
+$8.24M
4
Bank of America
Bank of America
North Carolina
+$6.47M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$4.54M

Top Sellers

Rank Fund Capital Flow
1
Group One Trading
Group One Trading
Illinois
-$16.8M
2
Voloridge Investment Management
Voloridge Investment Management
Florida
-$13.8M
3
SC
Sculptor Capital
New York
-$8.7M
4
CAC
Cowen and Company
New York
-$8.51M
5
Millennium Management
Millennium Management
New York
-$7.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
Verition Fund Management
101
Verition Fund Management
Connecticut
$213K +$255K +4,867 New
FA
102
Fermata Advisors
California
$211K -$14.4K -275 -5%
PNC Financial Services Group
103
PNC Financial Services Group
Pennsylvania
$180K – – –
US Bancorp
104
US Bancorp
Minnesota
$164K +$17.9K +342 +10%
PHK
105
Point72 Hong Kong
Hong Kong
$163K +$190K +3,627 +3,454%
VEA
106
Virtus ETF Advisers
New York
$153K +$36.8K +701 +25%
SO
107
STRS Ohio
Ohio
$139K -$267K -5,100 -61%
AIP
108
Ameritas Investment Partners
Nebraska
$131K – – –
Macquarie Group
109
Macquarie Group
Australia
$94K – – –
BAM
110
Byrne Asset Management
New Jersey
$94K +$113K +2,158 New
SAM
111
Shell Asset Management
Netherlands
$90K -$2.2K -42 -2%
Canada Life
112
Canada Life
Manitoba, Canada
$90K – – –
TRCT
113
Tower Research Capital (TRC)
New York
$85K +$7.03K +134 +7%
FDCDDQ
114
Federation des caisses Desjardins du Quebec
Quebec, Canada
$72.1K – – –
Rockefeller Capital Management
115
Rockefeller Capital Management
New York
$56K +$1.94K +37 +3%
RG
116
Retirement Group
California
$53K +$8.65K +165 +16%
HCM
117
Highlander Capital Management
New Jersey
$44K +$52.4K +1,000 New
CSS
118
Cubist Systematic Strategies
Connecticut
$40K -$296K -5,651 -86%
ACM
119
Aquatic Capital Management
Illinois
$31K +$36.7K +700 New
AWM
120
Avior Wealth Management
Nebraska
$31K +$38.3K +731 New
BWA
121
BDO Wealth Advisors
Florida
$26K +$21K +400 +200%
MA
122
Montag & Associates
Georgia
$22K -$4.98K -95 -16%
AWM
123
AllSquare Wealth Management
New York
$22K – – –
AA
124
Ancora Advisors
Ohio
$22K – – –
TWC
125
TD Waterhouse Canada
Ontario, Canada
$19.3K +$21K +400 New
3 4
5
6 7

FLNA Hedge Fund Activity: Q4 2021 in Review

171 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q4 2021, worth a combined $503M — down 34% from $757M a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of FLNA and 34 opened new positions — a net loss of 6 holders — while 52 trimmed existing stakes and 57 added.

The largest buyer was Think Investments, opening a new position worth an estimated $10.6M. The largest seller was Group One Trading, cutting an estimated $16.8M.

  • 171 institutional investors held Filana Therapeutics (FLNA) as of Q4 2021, down from 180 in Q3 2021.
  • Funds reported $503M of Filana Therapeutics stock for Q4 2021, down 34% quarter-over-quarter.
  • 34 funds opened new Filana Therapeutics positions in Q4 2021 and 40 closed out, a net change of -6 holders.
  • The largest Filana Therapeutics buyer in Q4 2021 was Think Investments, an estimated $10.6M added.
  • The largest Filana Therapeutics seller in Q4 2021 was Group One Trading, an estimated $16.8M sold.

Based on aggregated 13F filings for Q4 2021.